Lincolnshire Prescribing and Clinical Effectiveness Forum (PACEF) was founded in 2007. It is the current strategic advisory network to NHS Lincolnshire CCG. PACEF has the responsibility for ensuring the cost-effective use of medicines and other healthcare interventions and their functional integration into healthcare delivery across Lincolnshire.

Representation on the group is comprised of leading professionals from the Lincolnshire Clinical Commissioning Group, primary care, the local Acute Trusts (United Lincolnshire Hospitals Trust and Lincolnshire Partnership Foundation Trust), Lincolnshire Community Health Services, Local Medical Council and Local Pharmaceutical Council. 

PACEF Bulletins

Title
PACE Bulletin Vol 15 No 3 July 21

Description

Nortriptyline approved as GREEN unlicensed use for management of neuropathic pain.

Octasa® brand of mesalazine suppositories approved as AMBER 2 to be used first line when a suppository formulation is required.

Accu-Chek Performa Blood Glucose meters. Supply of these meters are being phased out July/ August 2021. Supply of test strips to remain for those already using this meter.

Instant Blood Glucose meter and test strips added to Lincolnshire formulary as second line Blood glucose meter as alternative to the Accu-Chek performa meter.

Deception® brand of apomorphine –approved as GREY for those patients under the care of external trusts.

Steroid containing rectal foams following Colifoam discontinuation only Budenofalk remains on the formulary.

Drug Safety Update July 2021 chloramphenicol eye drops containing borax or boric acid can now be administered to children younger than two years of age.

PACE Bulletin Vol 15 No 2 May 21

Description

Sumatriptan 3mg/0.5ml pre-filled pen (Ranbaxy approved as GREEN.

Tinzaparin – low molecular weight heparin approved as GREY for those patients under the care of external trusts.

Introduction of the Steroid Emergency Card.

PACE Bulletin Vol 15 No 1 Mar 21

Description

Semaglutide 3mg,7mg & 14 mg tablets ( Rybelsus) approved as AMBER 2.

Dapagliflozin 10mg tablets (Forxiga) approved as AMBER 2 for the treatment of heart failure.

FreeStyle Libre 2® sensors approved as AMBER 2 for use in line with NHS England guidance for Flash Glucose Monitors.

Levosert®- Levonorgestrel 20 micrograms/24 hours Intrauterine Delivery System, License change, duration of use for contraception extended to 6 years. Remains as GREEN on formulary, now classed as first choice intrauterine progesterone only contraceptive for women aged under 45 years of age.

Kyleena® Levonorgestrel 19.5mg intrauterine delivery system approved as GREEN when a lower dose progesterone only intrauterine device is required.

Methotrexate 2mg/ml oral solution (Jylamvo®) approved as AMBER 1.

Pilocarpine 5 mg film-coated tablets approved as AMBER 2.

Balsalazide sodium 750mg capsules (Colazide) approved as AMBER 2.